Editas Medicine Inc. | Key People and Executives
Katrine S. Bosley
President, Chief Executive Officer & Director
Jessica Hopfield
Independent Director
Andrew J. Hirsch
Independent Director
Akshay K. Vaishnaw
Independent Director
Boris Nikolic
Independent Director
Katrine S. Bosley
President, Chief Executive Officer & Director
Andrew A. F. Hack
Chief Financial & Accounting Officer
Gerald Cox
Chief Medical Officer
Charles Albright
Chief Scientific Officer
Vic Myer
Chief Technology Officer
Cristi Barnett
Media Contact
Mark Mullikin
Investor Relations Contact
Timothy D. Hunt
Senior Vice President-Corporate Affairs
Jessica Hopfield
Independent Director
Andrew J. Hirsch
Independent Director
Akshay K. Vaishnaw
Independent Director
Boris Nikolic
Independent Director
| Address |
11 Hurley Street
Cambridge Massachusetts 02142
United States
|
|
Employees
|
- |
| Website |
http://www.editasmedicine.com |
| Updated |
07/08/2019 |
| Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR); and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. |
